vs
LEGALZOOM.COM, INC.（LZ）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是LEGALZOOM.COM, INC.的1.2倍（$219.9M vs $190.3M），LEGALZOOM.COM, INC.净利率更高（3.2% vs -1.0%，领先4.2%），LEGALZOOM.COM, INC.同比增速更快（17.7% vs 2.0%），LEGALZOOM.COM, INC.自由现金流更多（$28.0M vs $16.8M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 4.5%）
LegalZoom是2001年成立的美国在线法律科技与服务企业，依托独立律师网络、旗下自营律所，结合自助服务技术与专属顾问，为用户提供线上法律服务。核心业务涵盖遗嘱、生前信托设立，营业执照、许可证办理等商事合规服务，以及版权登记、商标申请，同时还提供律师推荐等相关配套服务。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
LZ vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.2倍
$190.3M
营收增速更快
LZ
高出15.7%
2.0%
净利率更高
LZ
高出4.2%
-1.0%
自由现金流更多
LZ
多$11.2M
$16.8M
两年增速更快
OFIX
近两年复合增速
4.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $190.3M | $219.9M |
| 净利润 | $6.1M | $-2.2M |
| 毛利率 | 67.6% | 71.1% |
| 营业利润率 | 6.6% | 0.2% |
| 净利率 | 3.2% | -1.0% |
| 营收同比 | 17.7% | 2.0% |
| 净利润同比 | -52.9% | 92.4% |
| 每股收益（稀释后） | $0.03 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LZOFIX
| Q4 25 | $190.3M | $219.9M | ||
| Q3 25 | $190.2M | $205.6M | ||
| Q2 25 | $192.5M | $203.1M | ||
| Q1 25 | $183.1M | $193.6M | ||
| Q4 24 | $161.7M | $215.7M | ||
| Q3 24 | $168.6M | $196.6M | ||
| Q2 24 | $177.4M | $198.6M | ||
| Q1 24 | $174.2M | $188.6M |
净利润LZOFIX
| Q4 25 | $6.1M | $-2.2M | ||
| Q3 25 | $4.5M | $-22.8M | ||
| Q2 25 | $-266.0K | $-14.1M | ||
| Q1 25 | $5.1M | $-53.1M | ||
| Q4 24 | $12.9M | $-29.1M | ||
| Q3 24 | $11.1M | $-27.4M | ||
| Q2 24 | $1.3M | $-33.4M | ||
| Q1 24 | $4.7M | $-36.0M |
毛利率LZOFIX
| Q4 25 | 67.6% | 71.1% | ||
| Q3 25 | 67.3% | 72.2% | ||
| Q2 25 | 65.0% | 68.7% | ||
| Q1 25 | 63.7% | 62.8% | ||
| Q4 24 | 67.0% | 69.0% | ||
| Q3 24 | 67.5% | 68.7% | ||
| Q2 24 | 64.1% | 67.8% | ||
| Q1 24 | 60.7% | 67.5% |
营业利润率LZOFIX
| Q4 25 | 6.6% | 0.2% | ||
| Q3 25 | 3.4% | -8.3% | ||
| Q2 25 | -1.6% | -7.9% | ||
| Q1 25 | 4.9% | -25.2% | ||
| Q4 24 | 8.1% | -5.3% | ||
| Q3 24 | 9.6% | -9.6% | ||
| Q2 24 | 0.6% | -12.5% | ||
| Q1 24 | 2.9% | -15.6% |
净利率LZOFIX
| Q4 25 | 3.2% | -1.0% | ||
| Q3 25 | 2.4% | -11.1% | ||
| Q2 25 | -0.1% | -6.9% | ||
| Q1 25 | 2.8% | -27.4% | ||
| Q4 24 | 7.9% | -13.5% | ||
| Q3 24 | 6.6% | -13.9% | ||
| Q2 24 | 0.7% | -16.8% | ||
| Q1 24 | 2.7% | -19.1% |
每股收益（稀释后）LZOFIX
| Q4 25 | $0.03 | $-0.05 | ||
| Q3 25 | $0.02 | $-0.57 | ||
| Q2 25 | $0.00 | $-0.36 | ||
| Q1 25 | $0.03 | $-1.35 | ||
| Q4 24 | $0.07 | $-0.76 | ||
| Q3 24 | $0.06 | $-0.71 | ||
| Q2 24 | $0.01 | $-0.88 | ||
| Q1 24 | $0.02 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $203.1M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $171.9M | $450.0M |
| 总资产 | $511.5M | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LZOFIX
| Q4 25 | $203.1M | $82.0M | ||
| Q3 25 | $237.2M | $62.9M | ||
| Q2 25 | $217.0M | $65.6M | ||
| Q1 25 | $210.0M | $58.0M | ||
| Q4 24 | $142.1M | $83.2M | ||
| Q3 24 | $112.5M | $30.1M | ||
| Q2 24 | $118.8M | $26.4M | ||
| Q1 24 | $228.1M | $27.0M |
总债务LZOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益LZOFIX
| Q4 25 | $171.9M | $450.0M | ||
| Q3 25 | $201.9M | $442.5M | ||
| Q2 25 | $194.1M | $458.3M | ||
| Q1 25 | $187.2M | $458.3M | ||
| Q4 24 | $93.3M | $503.1M | ||
| Q3 24 | $60.1M | $525.9M | ||
| Q2 24 | $60.8M | $546.0M | ||
| Q1 24 | $167.9M | $570.3M |
总资产LZOFIX
| Q4 25 | $511.5M | $850.6M | ||
| Q3 25 | $551.1M | $832.6M | ||
| Q2 25 | $543.0M | $837.2M | ||
| Q1 25 | $532.7M | $823.1M | ||
| Q4 24 | $373.9M | $893.3M | ||
| Q3 24 | $348.8M | $867.9M | ||
| Q2 24 | $359.5M | $882.0M | ||
| Q1 24 | $459.7M | $906.0M |
负债/权益比LZOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $34.1M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $28.0M | $16.8M |
| 自由现金流率自由现金流/营收 | 14.7% | 7.6% |
| 资本支出强度资本支出/营收 | 3.2% | 4.9% |
| 现金转化率经营现金流/净利润 | 5.63× | — |
| 过去12个月自由现金流最近4个季度 | $147.9M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流LZOFIX
| Q4 25 | $34.1M | $27.7M | ||
| Q3 25 | $54.2M | $12.4M | ||
| Q2 25 | $39.1M | $11.6M | ||
| Q1 25 | $50.7M | $-18.4M | ||
| Q4 24 | $42.6M | $23.7M | ||
| Q3 24 | $31.6M | $11.7M | ||
| Q2 24 | $27.2M | $9.0M | ||
| Q1 24 | $34.2M | $-18.6M |
自由现金流LZOFIX
| Q4 25 | $28.0M | $16.8M | ||
| Q3 25 | $47.0M | $2.5M | ||
| Q2 25 | $31.6M | $4.5M | ||
| Q1 25 | $41.3M | $-25.1M | ||
| Q4 24 | $35.9M | $15.2M | ||
| Q3 24 | $22.0M | $6.3M | ||
| Q2 24 | $17.4M | $-360.0K | ||
| Q1 24 | $24.7M | $-29.1M |
自由现金流率LZOFIX
| Q4 25 | 14.7% | 7.6% | ||
| Q3 25 | 24.7% | 1.2% | ||
| Q2 25 | 16.4% | 2.2% | ||
| Q1 25 | 22.6% | -13.0% | ||
| Q4 24 | 22.2% | 7.0% | ||
| Q3 24 | 13.0% | 3.2% | ||
| Q2 24 | 9.8% | -0.2% | ||
| Q1 24 | 14.2% | -15.4% |
资本支出强度LZOFIX
| Q4 25 | 3.2% | 4.9% | ||
| Q3 25 | 3.8% | 4.8% | ||
| Q2 25 | 3.9% | 3.5% | ||
| Q1 25 | 5.1% | 3.5% | ||
| Q4 24 | 4.1% | 4.0% | ||
| Q3 24 | 5.7% | 2.7% | ||
| Q2 24 | 5.6% | 4.7% | ||
| Q1 24 | 5.4% | 5.6% |
现金转化率LZOFIX
| Q4 25 | 5.63× | — | ||
| Q3 25 | 12.03× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 9.89× | — | ||
| Q4 24 | 3.31× | — | ||
| Q3 24 | 2.86× | — | ||
| Q2 24 | 20.74× | — | ||
| Q1 24 | 7.21× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LZ
暂无分部数据
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
